https://scholars.lib.ntu.edu.tw/handle/123456789/533870
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Li Y.-H. | en_US |
dc.contributor.author | Fang C.-Y. | en_US |
dc.contributor.author | Hsieh I.-C. | en_US |
dc.contributor.author | Huang W.-C. | en_US |
dc.contributor.author | Lin T.-H. | en_US |
dc.contributor.author | Sung S.-H. | en_US |
dc.contributor.author | Chiu C.-Z. | en_US |
dc.contributor.author | Wu C.-J. | en_US |
dc.contributor.author | Shyu K.-G. | en_US |
dc.contributor.author | PO-YUAN CHANG | en_US |
dc.contributor.author | Fang C.-C. | en_US |
dc.contributor.author | Lu T.-M. | en_US |
dc.contributor.author | Chen C.-P. | en_US |
dc.contributor.author | Tai W.-C. | en_US |
dc.contributor.author | Sheu C.-C. | en_US |
dc.contributor.author | Wei K.-C. | en_US |
dc.contributor.author | Huang Y.-H. | en_US |
dc.contributor.author | Wu H.-M. | en_US |
dc.contributor.author | HWANG, JUEY-JEN | en_US |
dc.date.accessioned | 2020-12-28T07:15:32Z | - |
dc.date.available | 2020-12-28T07:15:32Z | - |
dc.date.issued | 2018 | - |
dc.identifier.issn | 1011-6842 | - |
dc.identifier.uri | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85047087310&doi=10.6515%2fACS.201805_34%283%29.20180302A&partnerID=40&md5=f7b013cf736157f619dd0e521f4a89c4 | - |
dc.identifier.uri | https://scholars.lib.ntu.edu.tw/handle/123456789/533870 | - |
dc.description.abstract | Antiplatelet therapy is a key component in the treatment of acute coronary syndrome (ACS). The management of ACS has evolved considerably over recent years with the development of new and more potent antiplatelet agents. Clinical trials on ACS have demonstrated that potent antiplatelet agents can more effectively reduce cardiovascular events. However, there is a tipping point between safety and efficacy, beyond which the risk of bleeding and other adverse effects can outweigh the benefits of antiplatelet therapy. Striking a balance between safety and efficacy remains a major challenge. A consensus meeting of an expert panel composed of Taiwanese experts was held to provide recommendations for the management of adverse effects in patients with ACS receiving antiplatelet therapy. The common adverse effects of antiplatelet therapy include upper gastrointestinal bleeding, ecchymosis, hematuria, epistaxis and ticagrelor-related dyspnea. In this study, a literature review of these adverse events was performed and recommendations for the management were made. ? 2018, Republic of China Society of Cardiology. All rights reserved. | - |
dc.publisher | Republic of China Society of Cardiology | - |
dc.relation.ispartof | Acta Cardiologica Sinica | - |
dc.subject.classification | [SDGs]SDG3 | - |
dc.subject.other | acetylsalicylic acid; antithrombocytic agent; clopidogrel; ticagrelor; acute coronary syndrome; acute heart infarction; bleeding; brain hemorrhage; cardiovascular disease; cerebrovascular accident; dual antiplatelet therapy; dyspnea; ecchymosis; epistaxis; gastrointestinal hemorrhage; hematuria; hemopericardium; hemoptysis; human; intraocular hemorrhage; perforation; randomized controlled trial (topic); retroperitoneal hemorrhage; Review; risk factor; Taiwan; treatment outcome; ulcer; upper gastrointestinal bleeding | - |
dc.title | 2018 expert consensus on the management of adverse effects of antiplatelet therapy for acute coronary syndrome in Taiwan | en_US |
dc.type | review | en |
dc.identifier.doi | 10.6515/ACS.201805_34(3).20180302A | - |
dc.identifier.scopus | 2-s2.0-85047087310 | - |
dc.relation.pages | 201-210 | - |
dc.relation.journalvolume | 34 | - |
dc.relation.journalissue | 3 | - |
item.fulltext | no fulltext | - |
item.openairecristype | http://purl.org/coar/resource_type/c_18cf | - |
item.cerifentitytype | Publications | - |
item.openairetype | review | - |
item.grantfulltext | none | - |
crisitem.author.dept | Internal Medicine | - |
crisitem.author.dept | Internal Medicine-NTUH | - |
crisitem.author.dept | Internal Medicine | - |
crisitem.author.orcid | 0000-0001-5536-0175 | - |
crisitem.author.orcid | 0000-0001-6437-0455 | - |
crisitem.author.parentorg | College of Medicine | - |
crisitem.author.parentorg | National Taiwan University Hospital | - |
crisitem.author.parentorg | College of Medicine | - |
Appears in Collections: | 醫學系 |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.